3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
2
Drug-Related Side Effects and Adverse Reactions
2
Central Nervous System Neoplasms
2
Thrombocytopenia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Liposarcoma
1
Intraocular Lymphoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Astrocytoma
1
Interventions
thymoglobulin
2
Thiotepa
2
Stem Cell Transplantation
2
Melphalan
2
Ifosfamide
2
Etoposide
2
Bone Marrow Transplantation
2
Antilymphocyte Serum
2
sodium thiosulfate
1
ribociclib
1
omburtamab I-131
1
lexatumumab
1
ganitumab
1
fludarabine phosphate
1
copanlisib
1
bempegaldesleukin
1
X-Rays
1
Vincristine
1
Topotecan
1
Temozolomide
1
Tacrolimus
1
Specimen Handling
1
Rituximab
1
Receptor Protein-Tyrosine Kinases
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Polymerase Chain Reaction
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Rhabdomyosarcoma
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled